CFD merupakan instrumen yang rumit dan memiliki risiko tinggi kehilangan uang secara cepat karena adanya pengaruh leverage. 84% akun investor ritel mengalami kerugian saat melakukan kegiatan perdagangan CFD dengan penyedia ini. Anda harus mempertimbangkan apakah Anda memahami cara kerja CFD dan apakah Anda mampu menerima risiko tinggi kehilangan uang.

Scan to Download iOS&Android APP

Perdagangan Fresenius Medical Care AG & Co KGaA - FME CFD

36.67
0.6%
0.16
Rendah: 35.81
Tinggi: 36.99
Market Trading Hours* (UTC) Open now
Closes on Monday at 16:30

Mon - Fri: 08:00 - 16:30

  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
  • Ownership
Trading Conditions
Spread 0.16
Biaya inap posisi Long

Long position overnight fee


Margin. Your investment $1,000.00
Biaya Overnight -0.017913 %
Charges from borrowed part ($-0.72)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

Kunjungi platform
-0.017913%
Biaya inap posisi short

Short position overnight fee


Margin. Your investment $1,000.00
Biaya Overnight -0.004309 %
Charges from borrowed part ($-0.17)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

Kunjungi platform
-0.004309%
Waktu biaya inap 21:00 (UTC)
Kuantitas min. yang diperdagangkan 1
Mata uang EUR
Margin 20%
Bursa efek Germany
Komisi perdagangan 0%

*Information provided by Capital.com

Fresenius Medical Care AG & Co KGaA ESG Risk Ratings

High Medium Low Negligible

‘B’ score indicates good relative ESG performance and above average degree of transparency in reporting material ESG data publicly.

Key Stats
Prev. Close* 36.55
Open* 36.43
1-Year Change* -39.44%
Day's Range* 35.81 - 36.99
52 wk Range 25.95-63.66
Average Volume (10 days) 1.32M
Average Volume (3 months) 16.76M
Market Cap 10.85B
P/E Ratio 16.10
Shares Outstanding 293.41M
Revenue 19.40B
EPS 2.30
Dividend (Yield %) 3.02785
Beta 0.84
Next Earnings Date May 9, 2023

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Mar 17, 2023 36.52 -0.16 -0.44% 36.68 37.73 35.77
Mar 16, 2023 36.62 -0.31 -0.84% 36.93 37.27 36.34
Mar 15, 2023 36.85 -0.44 -1.18% 37.29 37.46 36.47
Mar 14, 2023 37.16 -0.02 -0.05% 37.18 37.30 36.42
Mar 13, 2023 37.06 0.31 0.84% 36.75 37.51 36.08
Mar 10, 2023 36.99 1.26 3.53% 35.73 36.99 35.65
Mar 9, 2023 36.31 0.29 0.81% 36.02 36.45 35.84
Mar 8, 2023 36.24 0.51 1.43% 35.73 36.25 35.69
Mar 7, 2023 36.06 -0.53 -1.45% 36.59 36.78 35.84
Mar 6, 2023 37.45 0.61 1.66% 36.84 37.71 36.69
Mar 3, 2023 36.50 0.79 2.21% 35.71 36.51 35.67
Mar 2, 2023 35.62 0.27 0.76% 35.35 36.01 35.33
Mar 1, 2023 35.36 -1.16 -3.18% 36.52 36.76 35.31
Feb 28, 2023 36.87 -0.83 -2.20% 37.70 37.75 36.70
Feb 27, 2023 38.06 0.29 0.77% 37.77 38.28 37.71
Feb 24, 2023 37.68 0.24 0.64% 37.44 38.31 37.37
Feb 23, 2023 37.67 -1.35 -3.46% 39.02 39.06 36.74
Feb 22, 2023 39.62 0.68 1.75% 38.94 42.14 38.74
Feb 21, 2023 37.09 -0.84 -2.21% 37.93 38.00 36.99
Feb 20, 2023 37.65 0.77 2.09% 36.88 37.70 36.67

Fresenius Medical Care AG & Co KGaA Events

Time (UTC) Country Event
No events scheduled
View all events
  • Annual
  • Quarterly
2016 2017 2018 2019 2020 2021
Total revenue 16569.7 17783.6 16546.9 17476.6 17859.1 17618.7
Revenue 16569.7 17783.6 16546.9 17476.6 17859.1 17618.7
Cost of Revenue, Total 10953.8 11765.3 11392.1 12080.7 12321.6 12541.7
Gross Profit 5615.95 6018.25 5154.74 5395.85 5537.44 5077.03
Total Operating Expense 14160.8 15421.1 13509.1 15207 15554.7 15766.4
Selling/General/Admin. Expenses, Total 3118.73 3349.71 2709.78 2939.13 3173.55 3125.99
Research & Development 145.787 130.272 133.274 164.976 188.75 214.345
Depreciation / Amortization 0.724 0.432 0.341 3.052 5.024 6.437
Interest Expense (Income) - Net Operating -55.727 -30.797 -65.408 -73.611 -94.518 -92.175
Unusual Expense (Income) -2.469 206.196 -661.043 92.744 -39.769 -29.857
Operating Income 2408.9 2362.44 3037.8 2269.56 2304.41 1852.29
Interest Income (Expense), Net Non-Operating -363.408 -364.824 -301.062 -429.444 -368.019 -280.429
Net Income Before Taxes 2045.49 1997.61 2736.74 1840.11 1936.39 1571.86
Net Income After Taxes 1420.05 1554.53 2225.66 1438.5 1435.83 1219.03
Minority Interest -276.072 -274.746 -243.733 -238.881 -271.455 -249.72
Net Income Before Extra. Items 1143.98 1279.79 1981.92 1199.62 1164.38 969.308
Net Income 1143.98 1279.79 1981.92 1199.62 1164.38 969.308
Income Available to Common Excl. Extra. Items 1143.98 1279.79 1981.92 1199.62 1164.38 969.308
Income Available to Common Incl. Extra. Items 1143.98 1279.79 1981.92 1199.62 1164.38 969.308
Diluted Net Income 1143.98 1279.79 1981.92 1199.62 1164.38 969.308
Diluted Weighted Average Shares 306.697 307.641 307.275 302.691 294.056 292.945
Diluted EPS Excluding Extraordinary Items 3.73 4.16 6.45 3.96318 3.95972 3.30884
Dividends per Share - Common Stock Primary Issue 0.96 1.06 1.17 1.2 1.34 1.35
Diluted Normalized EPS 3.72441 4.68158 4.70044 4.2027 4.48488 3.62772
Q1 2021 Q2 2021 Q3 2021 Q4 2021 Q1 2022
Total revenue 4210.12 4320.17 4441.37 4647.02 4548.37
Revenue 4210.12 4320.17 4441.37 4647.02 4548.37
Cost of Revenue, Total 3003.47 3036.18 3174.15 3327.86 3290.27
Gross Profit 1206.66 1283.99 1267.22 1319.16 1258.09
Total Operating Expense 3735.87 3895.95 3936.71 4197.87 4200.7
Selling/General/Admin. Expenses, Total 711.515 830.177 731.23 823.21 871.241
Research & Development 47.343 50.736 50.571 65.701 47.607
Depreciation / Amortization 1.302 1.281 1.791 2.057 2.066
Interest Expense (Income) - Net Operating -27.756 -22.422 -21.036 -20.961 -10.487
Operating Income 474.253 424.221 504.661 449.155 347.668
Interest Income (Expense), Net Non-Operating -76.072 -69.209 -68.436 -66.712 -69.097
Net Income Before Taxes 398.181 355.012 436.225 382.443 278.571
Net Income After Taxes 304.334 279.718 331.235 303.741 211.806
Minority Interest -55.388 -61.141 -58.191 -75 -54.445
Net Income Before Extra. Items 248.946 218.577 273.044 228.741 157.361
Net Income 248.946 218.577 273.044 228.741 157.361
Income Available to Common Excl. Extra. Items 248.946 218.577 273.044 228.741 157.361
Income Available to Common Incl. Extra. Items 248.946 218.577 273.044 228.741 157.361
Diluted Net Income 248.946 218.577 273.044 228.741 157.361
Diluted Weighted Average Shares 292.878 292.914 292.986 293 293.007
Diluted EPS Excluding Extraordinary Items 0.85 0.74622 0.93194 0.78069 0.53706
Dividends per Share - Common Stock Primary Issue 0 0 0 1.35 0
Diluted Normalized EPS 1.04311 0.91837 1.18851 1.14933 0.78617
  • Annual
  • Quarterly
2016 2017 2018 2019 2020 2021
Total Current Assets 6883.95 6374.31 7846.89 7165.15 7275.31 7967.24
Cash and Short Term Investments 959.627 993.574 2265.14 1141.05 1243.23 1618.02
Cash 667.139 620.145 831.885 768.706 746.851 925.134
Cash & Equivalents 41.743 357.964 1313.75 239.017 334.688 556.521
Short Term Investments 250.745 15.465 119.507 133.322 161.688 136.362
Total Receivables, Net 3930.82 3696.15 3765.57 3969.26 3579.29 3769.23
Accounts Receivable - Trade, Net 3343.82 3389.33 3337.71 3421.35 3153.04 3409.06
Total Inventory 1337.48 1290.78 1466.8 1663.28 1895.31 2038.01
Prepaid Expenses 378.85 124.162 135.729 178.474 374.081 377.907
Other Current Assets, Total 277.175 269.64 213.646 213.086 183.398 164.07
Total Assets 25503.5 24025.2 26242.3 32934.7 31689 34366.6
Property/Plant/Equipment, Total - Net 3579.63 3491.77 3836.01 8515.4 8186.75 8551.47
Property/Plant/Equipment, Total - Gross 7744.96 7655.4 8507.4 14413.4 14830.4 16654.3
Accumulated Depreciation, Total -4165.34 -4163.63 -4671.39 -5897.98 -6643.68 -8102.86
Goodwill, Net 12955.6 12103.9 12209.6 14017.3 12958.7 14361.6
Intangibles, Net 803.12 683.058 681.331 1426.33 1381.01 1459.39
Long Term Investments 598.154 647.009 649.78 696.872 761.113 786.905
Other Long Term Assets, Total 683.117 725.149 1018.66 1113.74 1126.12 1239.97
Total Current Liabilities 5298.9 5299.89 6268.28 7007.23 6159.64 7257.63
Accounts Payable 575.556 590.493 641.271 716.526 731.993 736.069
Accrued Expenses 2278.79 2056.18 2056.49 1964.24 2115.75 2225.56
Notes Payable/Short Term Debt 575.01 769.279 1394.19 1171.85 79.27 1255.85
Current Port. of LT Debt/Capital Leases 840.338 994.731 1244.73 2086.16 1617.52 1329.54
Other Current Liabilities, Total 1029.2 889.211 931.597 1068.46 1615.11 1710.61
Total Liabilities 15525.9 14205.1 14483.9 20976.8 20474 21667.8
Total Long Term Debt 6832.89 5794.87 5045.52 10524.6 10683.2 10734.8
Long Term Debt 6800.32 5766 5018.76 6458.32 6800.1 6646.95
Capital Lease Obligations 32.564 28.873 26.757 4066.3 3883.13 4087.8
Deferred Income Tax 661.921 467.54 626.521 739.702 785.886 868.452
Minority Interest 1073.47 1008.08 1143.55 1269.32 1116.23 1280.25
Other Liabilities, Total 1658.7 1634.72 1399.99 1435.95 1728.96 1526.68
Total Equity 9977.66 9820.1 11758.4 11957.9 11215.1 12698.8
Common Stock 307.222 308.111 307.879 304.437 292.877 293.004
Additional Paid-In Capital 3960.11 3969.25 3873.34 3607.66 2872.63 2891.28
Retained Earnings (Accumulated Deficit) 6085.88 7137.25 8831.93 9454.86 10254.9 10826.1
Treasury Stock - Common -50.993 -108.931 -50.993 -370.502 0
Other Equity, Total -324.563 -1485.58 -1203.75 -1038.55 -2205.34 -1311.64
Total Liabilities & Shareholders’ Equity 25503.5 24025.2 26242.3 32934.7 31689 34366.6
Total Common Shares Outstanding 306.222 306.451 306.879 298.329 292.877 293.004
Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022
Total Current Assets 7789.41 7814.68 7998.91 7967.24 8039.39
Cash and Short Term Investments 1073.48 1407.96 1561.83 1481.66 1173.34
Cash & Equivalents 1073.48 1407.96 1561.83 556.521 1173.34
Total Receivables, Net 3894.15 3526.45 3449.86 3571.42 3890.82
Accounts Receivable - Trade, Net 3740.71 3419.51 3323.6 3409.06 3707.49
Total Inventory 1989.41 2052.94 2119.8 2038.01 2136.96
Other Current Assets, Total 832.376 827.332 867.414 876.151 838.272
Total Assets 33158.5 32987.2 33830.9 34366.6 34724.1
Property/Plant/Equipment, Total - Net 8415.64 8320.06 8391.22 8551.47 8510.45
Goodwill, Net 13638.9 13495.5 13901.4 14361.6 14628.7
Intangibles, Net 1401.5 1395.03 1418.94 1459.39 1480.42
Long Term Investments 726.595 708.56 742.799 786.905 798.947
Other Long Term Assets, Total 1186.48 1253.37 1377.62 1239.97 1266.2
Total Current Liabilities 7242.97 7424.63 7492.3 7257.63 6377.45
Accounts Payable 635.422 684.981 706.385 736.069 790.236
Accrued Expenses 3792.75 3850.79 3885.14 3676.88 3515.83
Notes Payable/Short Term Debt 1140.62 1385.03 1363.29 1255.85 1115.21
Current Port. of LT Debt/Capital Leases 1423.64 1261.47 1293.77 1329.54 730.959
Other Current Liabilities, Total 250.54 242.356 243.715 259.293 225.212
Total Liabilities 21160.5 21355.3 21601.2 21667.8 21489.6
Total Long Term Debt 10336.2 10469 10570.1 10734.8 11497.2
Long Term Debt 6315.27 6499 6571.22 6646.95 7451.79
Capital Lease Obligations 4020.95 3970.02 3998.86 4087.8 4045.41
Deferred Income Tax 809.215 800.492 863.9 868.452 896.38
Minority Interest 1201.58 1180.48 1216.24 1280.25 1304.8
Other Liabilities, Total 1570.47 1480.62 1458.73 1526.68 1413.8
Total Equity 11998.1 11632 12229.7 12698.8 13234.5
Common Stock 292.888 292.979 292.994 293.004 293.027
Additional Paid-In Capital 2887.04 2886.97 2884.96 2891.28 2891.74
Retained Earnings (Accumulated Deficit) 10500 10290.6 10567.7 10826.1 11027.2
Other Equity, Total -1681.86 -1838.63 -1515.97 -1311.64 -977.445
Total Liabilities & Shareholders’ Equity 33158.5 32987.2 33830.9 34366.6 34724.1
Total Common Shares Outstanding 292.888 292.979 292.994 293.004 293.027
Cash 925.134
  • Annual
  • Quarterly
2016 2017 2018 2019 2020 2021
Net income/Starting Line 1420.05 1554.53 2225.66 1438.5 1435.83 1219.03
Cash From Operating Activities 1931.97 2191.81 2061.91 2566.95 4233.16 2489.5
Cash From Operating Activities 701.536 735.479 724.847 1593.16 1785.9 1623.68
Deferred Taxes 0.232 -203.046 89.171 64.266 111.104 67.259
Non-Cash Items -27.609 -126.822 -824.73 304.705 215.137 232.342
Cash Taxes Paid 541.075 674.625 358.386 387.719 301.663 345.052
Cash Interest Paid 349.738 339.088 311.971 470.223 379.994 341.629
Changes in Working Capital -162.238 231.666 -153.034 -833.68 685.184 -652.807
Cash From Investing Activities -1246.12 -991.541 -245.039 -3285.99 -1334.94 -1196.23
Capital Expenditures -942.691 -970.83 -1142.38 -1162.76 -1085.23 -886.715
Other Investing Cash Flow Items, Total -303.425 -20.711 897.34 -2123.22 -249.709 -309.513
Cash From Financing Activities -519.717 -798.63 -681.736 -466.633 -2664.03 -1024.38
Financing Cash Flow Items -110.367 -185.979 -528.009 153.387 -693.531 -279.535
Total Cash Dividends Paid -244.251 -293.973 -324.838 -354.636 -351.17 -392.455
Issuance (Retirement) of Stock, Net 47.467 -10.347 10.183 -583.932 -353.335 6.511
Issuance (Retirement) of Debt, Net -212.566 -308.331 160.928 318.548 -1265.99 -358.903
Foreign Exchange Effects 38.012 -132.413 32.387 47.76 -160.371 131.228
Net Change in Cash 204.152 269.227 1167.52 -1137.91 73.816 400.116
Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022
Net income/Starting Line 304.334 584.052 915.287 1219.03 211.806
Cash From Operating Activities 207.648 1128.77 1820.45 2489.5 158.697
Cash From Operating Activities 388.202 783.735 1186.57 1623.68 418.957
Deferred Taxes -6.054 -36.814 -12.828 67.259 -9.295
Non-Cash Items 40.292 91.471 116.658 232.342 54.974
Cash Taxes Paid 41.793 209.901 268.11 345.052 44.301
Cash Interest Paid 104.607 171.384 255.162 341.629 79.484
Changes in Working Capital -519.126 -293.674 -385.234 -652.807 -517.745
Cash From Investing Activities -224.053 -473.178 -773.438 -1196.23 -211.316
Capital Expenditures -290.79 -522.335 -858.778 -854.36 -198.313
Other Investing Cash Flow Items, Total 66.737 49.157 85.34 -341.868 -13.003
Cash From Financing Activities -35.915 -378.319 -666.849 -1024.38 -266.641
Financing Cash Flow Items -47.907 -133.871 -208.996 -279.535 464.211
Issuance (Retirement) of Stock, Net 0.575 5.228 6.005 6.511 0.792
Issuance (Retirement) of Debt, Net 11.417 142.779 -71.403 -358.903 -731.644
Foreign Exchange Effects 44.259 49.146 100.131 131.228 10.947
Net Change in Cash -8.061 326.419 480.295 400.116 -308.313
Total Cash Dividends Paid -392.455 -392.455 -392.455
Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
Fresenius SE & Co KGaA Corporation 32.1663 94380382 0 2023-01-02 LOW
Pzena Investment Management, LLC Investment Advisor/Hedge Fund 5.2 15257499 6433048 2023-01-02 LOW
BlackRock Institutional Trust Company, N.A. Investment Advisor 3.6546 10723179 -5306 2023-01-04 LOW
Harris Associates L.P. Investment Advisor/Hedge Fund 3.0098 8831173 15678 2023-02-28 LOW
Dodge & Cox Investment Advisor/Hedge Fund 3.0017 8807448 -5315479 2023-01-03 LOW
Artisan Partners Limited Partnership Investment Advisor 2.9941 8785062 0 2023-01-02 LOW
Templeton Investment Counsel, L.L.C. Investment Advisor/Hedge Fund 2.659 7801761 200236 2023-01-31 LOW
The Vanguard Group, Inc. Investment Advisor/Hedge Fund 2.0365 5975404 11399 2023-02-28 LOW
Norges Bank Investment Management (NBIM) Sovereign Wealth Fund 1.2147 3564186 -379946 2022-12-31 LOW
DWS Investment GmbH Investment Advisor/Hedge Fund 1.0853 3184497 105149 2023-02-28 LOW
Fidelity International Investment Advisor 0.9623 2823645 47140 2023-01-31 LOW
Lazard Asset Management, L.L.C. Investment Advisor/Hedge Fund 0.8532 2503267 0 2023-02-28 LOW
BlackRock Advisors (UK) Limited Investment Advisor/Hedge Fund 0.5802 1702442 36990 2023-02-28 LOW
Macquarie Investment Management Investment Advisor 0.5594 1641311 -6380 2023-02-28 LOW
Deka Investment GmbH Investment Advisor/Hedge Fund 0.5432 1593946 25473 2023-02-28 LOW
Fiduciary Management, Inc. Investment Advisor 0.506 1484650 130000 2022-12-31 LOW
Dimensional Fund Advisors, L.P. Investment Advisor/Hedge Fund 0.4893 1435667 839 2023-02-28 LOW
PGGM Vermogensbeheer B.V. Pension Fund 0.4572 1341369 -44634 2021-12-31 LOW
Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 0.4514 1324441 10743 2023-02-28 LOW
BlackRock Asset Management Deutschland AG Investment Advisor 0.4436 1301694 81837 2023-02-28 LOW

Mengapa memilih Capital.com? Biarlah angka kami yang berbicara.

Capital.com Group
500000+

Trader

92000+

Klien aktif per bulan

$53000000+

Volume investasi per bulan

$30000000+

Penarikan tiap bulan

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long
Industry: Healthcare Facilities & Services (NEC)

Else-Kröner-Straße 1
BAD HOMBURG VOR DER HOHE
HESSEN 61352
DE

Income Statement

  • Annual
  • Quarterly

People also watch

XRP/USD

0.39 Price
-1.170% 1D Chg, %
Biaya inap posisi Long -0.0753%
Biaya inap posisi short 0.0069%
Waktu biaya inap 21:00 (UTC)
Spread 0.00417

Gold

1,981.97 Price
-0.120% 1D Chg, %
Biaya inap posisi Long -0.0167%
Biaya inap posisi short 0.0084%
Waktu biaya inap 21:00 (UTC)
Spread 0.30

US100

12,504.60 Price
-0.030% 1D Chg, %
Biaya inap posisi Long -0.0241%
Biaya inap posisi short 0.0018%
Waktu biaya inap 21:00 (UTC)
Spread 1.8

Oil - Crude

65.79 Price
-0.900% 1D Chg, %
Biaya inap posisi Long -0.0201%
Biaya inap posisi short -0.0018%
Waktu biaya inap 21:00 (UTC)
Spread 0.03

Masih mencari broker yang bisa Anda percayai?

Bergabung dengan 500.000+ trader di seluruh dunia yang telah memilih trading bersama Capital.com

1. Buat & verifikasi akun Anda 2. Lakukan deposit 3. Temukan trading Anda